{
  "id": "3ca27c7843597802",
  "title": "New FDA Drug Reforms : Congress Extends Voucher Incentive , Clarifies Orphan Exclusivity and Provides Greater Transparency for Q1 / Q2 Generic Approvals | Polsinelli",
  "description": "20260219T071500Z",
  "content": "",
  "source": "jdsupra.com",
  "source_url": "https://www.jdsupra.com/legalnews/new-fda-drug-reforms-congress-extends-7248203/",
  "published_at": "20260219T071500Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.jdsupra.com/legalnews/new-fda-drug-reforms-congress-extends-7248203/",
    "url_mobile": "",
    "title": "New FDA Drug Reforms : Congress Extends Voucher Incentive , Clarifies Orphan Exclusivity and Provides Greater Transparency for Q1 / Q2 Generic Approvals | Polsinelli",
    "seendate": "20260219T071500Z",
    "socialimage": "https://jdsupra-static.s3.amazonaws.com/profile-images/og.13597_1843.jpg",
    "domain": "jdsupra.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}